Skip to main content
Year archive

SYNTARA LIMITED — 2010 filings

All 77 regulatory filings released by SYNTARA LIMITED (SNT) in 2010, sourced directly from the official regulator.

77 Filings
2010 Period
2010 filings (77)
Filing Released Lang
Share Trading Policy 8 pages ?Kb
Governance Information
2010-12-20 English
Appendix 3B - Exercise of Employee Options 11 pages ?Kb
Share Issue/Capital Change
2010-12-20 English
Bronchitol EU Marketing Authorisation Update 2 pages ?Kb
Regulatory Filings
2010-12-19 English
Extended Benefit with Bronchitol in Second PhaseIII CF Trial 2 pages ?Kb
Regulatory Filings
2010-12-15 English
Pharmaxis Holds Pre-NDA Meeting with FDA for Bronchitol 2 pages ?Kb
Regulatory Filings
2010-12-14 English
Ceasing to be a substantial holder 3 pages ?Kb
Major Shareholding Notification
2010-12-13 English
Bronchitol Recommended for Approval by Australian Advisory C 2 pages ?Kb
Regulatory Filings
2010-12-12 English
Phase II Trial of ASM8 in Asthma Commences 3 pages ?Kb
Regulatory Filings
2010-12-06 English
Appendix 3B - Exercise of Employee Options 11 pages ?Kb
Share Issue/Capital Change
2010-11-29 English
Appendix 3B - Exercise of Employee Options 11 pages ?Kb
Share Issue/Capital Change
2010-11-24 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2010-11-24 English
Appendix 3B Exercise of Employee Options 11 pages ?Kb
Share Issue/Capital Change
2010-11-15 English
Appendix 3B - Grant of Employee Performance Rights 10 pages ?Kb
Share Issue/Capital Change
2010-11-14 English
Updated Investor Presentation 37 pages ?Kb
Investor Presentation
2010-11-08 English
Appendix 3B - Exercise of Employee Options 11 pages ?Kb
Share Issue/Capital Change
2010-11-07 English
APpendix 3B - Exercise of Employee Options 11 pages ?Kb
Capital/Financing Update
2010-11-01 English
Appendix 3B - Exercise of Employee Options 11 pages ?Kb
Share Issue/Capital Change
2010-10-27 English
Pharmaxis Announces Positive Combined Phase 3 CF Results 3 pages ?Kb
Regulatory Filings
2010-10-21 English
Appendix 3B - Exercise of Employee Options 11 pages ?Kb
Share Issue/Capital Change
2010-10-21 English
Becoming a substantial holder 2 pages ?Kb
Major Shareholding Notification
2010-10-20 English
Pharmaxis CEO Resumes Office 1 page ?Kb
Board/Management Information
2010-10-19 English
Chairman`s Address to 2010 AGM 2 pages ?Kb
AGM Information
2010-10-19 English
CEO Presentation to 2010 AGM 36 pages ?Kb
Investor Presentation
2010-10-19 English
Results of Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements
2010-10-19 English
Appendix 3B - Option Issue 11 pages ?Kb
Capital/Financing Update
2010-10-19 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2010-10-19 English
Quarterly Report to Shareholders 8 pages ?Kb
Interim / Quarterly Report
2010-10-12 English
Appendix 4C - quarterly 5 pages ?Kb
Interim / Quarterly Report
2010-10-12 English
Becoming a substantial holder 7 pages ?Kb
Regulatory Filings
2010-10-11 English
Quarterly Investor Conference Call 1 page ?Kb
Regulatory Filings
2010-10-11 English
US FDA APPROVES ARIDOL 2 pages ?Kb
Regulatory Filings
2010-10-05 English
Appendix 3B - grant of employee equity 12 pages ?Kb
Capital/Financing Update
2010-09-26 English
Statutory Annual Report 89 pages ?Kb
Regulatory Filings
2010-09-09 English
Pharmaxis 2010 Annual Review 8 pages ?Kb
Annual Report
2010-09-09 English
Notice of 2010 Annual General Meeting/Proxy Form 9 pages ?Kb
AGM Information
2010-09-09 English
Appendix 3B - annual grant of employee options 11 pages ?Kb
Capital/Financing Update
2010-09-07 English
Proposed issue of options to CEO 1 page ?Kb
Capital/Financing Update
2010-09-07 English
Agreement for European Marketing of Bronchitol 2 pages ?Kb
Regulatory Filings
2010-08-30 English
Preliminary Final Report 48 pages ?Kb
Annual Report
2010-08-11 English
Exercise of Employee Options 10 pages ?Kb
Share Issue/Capital Change
2010-07-26 English
Appendix 4C - quarterly 5 pages ?Kb
Interim / Quarterly Report
2010-07-20 English
Quarterly Report to Shareholders - June 2010 8 pages ?Kb
Interim / Quarterly Report
2010-07-20 English
Quarterly Investor Conference Call Details 1 page ?
Regulatory Filings
2010-07-19 English
Update on Pharmaxis CEO 1 page ?Kb
Board/Management Information
2010-07-07 English
Ceasing to be a substantial holder 1 page ?Kb
Major Shareholding Notification
2010-06-24 English
Updated Investor Presentation 35 pages ?Kb
Investor Presentation
2010-06-23 English
Investor Conference Call - Clinical Trial Results 1
Call Transcript
2010-06-21 English
Results for Second Phase 3 Trial of Bronchitol in CF 4 pages ?Kb
Regulatory Filings
2010-06-21 English
Trading Halt 2 pages ?Kb
Regulatory Filings
2010-06-20 English
Pharmaxis CEO 1 page ?Kb
Regulatory Filings
2010-06-17 English
Exercise of Employee Options 10 pages ?Kb
Capital/Financing Update
2010-05-30 English
Sustained Benefit Following 18 Month Bronchitol Treatment 3 pages ?Kb
Regulatory Filings
2010-05-16 English
Appendix 3B - Exercise of Employee Options 10 pages ?Kb
Share Issue/Capital Change
2010-04-29 English
Pharmaxis resubmission for Aridol US marketing application 2 pages ?Kb
Regulatory Filings
2010-04-26 English
Appendix 3B - Exercise of Employee Options 10 pages ?Kb
Share Issue/Capital Change
2010-04-22 English
Change in substantial holding 4 pages ?Kb
Regulatory Filings
2010-04-21 English
Pharmaxis Announces Milestone in Phase 3 Trial for CF 2 pages ?Kb
Regulatory Filings
2010-04-13 English
March 2010 Quarterly Report to Shareholders 8 pages ?Kb
Interim / Quarterly Report
2010-04-13 English
Appendix 4C - quarterly March 2010 5 pages ?Kb
Interim / Quarterly Report
2010-04-13 English
PHARMAXIS QUARTERLY INVESTOR CONFERENCE CALL 1 page
Call Transcript
2010-04-11 English
Appendix 3B - Exercise of Employee Options 10 pages ?Kb
Capital/Financing Update
2010-03-22 English
Appendix 3B - Topigen Milestone Payment 10 pages ?Kb
Capital/Financing Update
2010-03-14 English
Disclosure notice under section 708A(5)(e) 1 page ?
Share Issue/Capital Change
2010-03-14 English
Pharmaxis Completes Phase II Clinical Study with ASM8 3 pages ?Kb
Capital/Financing Update
2010-03-10 English
Change in substantial holding 2 pages ?Kb
Major Shareholding Notification
2010-03-09 English
Investor Presentation 36 pages ?Kb
Investor Presentation
2010-03-01 English
Pharmaxis completes clinical trial with PXS25 2 pages ?Kb
Regulatory Filings
2010-02-08 English
Pharmaxis completes acquisition of Topigen Pharmaceuticals 2 pages ?Kb
Capital/Financing Update
2010-02-08 English
Appendix 3B - Topigen Acquisition 10 pages ?Kb
Capital/Financing Update
2010-02-08 English
Disclosure notice under section 708A(5) of Corporations Act 1
Capital/Financing Update
2010-02-08 English
Half Yearly Report and Accounts 19 pages ?Kb
Interim / Quarterly Report
2010-02-04 English
Appendix 3B - Exercise of Employee Options 10 pages ?Kb
Share Issue/Capital Change
2010-02-04 English
Updated Investor Presentation 31 pages ?Kb
Investor Presentation
2010-01-27 English
December 2009 Quarterly Report to Shareholders 8 pages ?Kb
Interim / Quarterly Report
2010-01-26 English
Appendix 4C - Quarterly Cash Flow 5 pages ?Kb
Interim / Quarterly Report
2010-01-26 English
Investor Conference Call 1 page ?Kb
Regulatory Filings
2010-01-21 English
Pharmaxis to acquire Canadian company TOPIGEN Pharmaceutical 3 pages ?Kb
M&A Activity
2010-01-11 English